Kraft Heinz (KHC) stock analysis for 2026. We assess the Berkshire Hathaway stake reduction, the $5.76 billion net loss from goodwill impairments, CEO Cahillane's $600M brand reinvestment plan, organic sales decline, GLP-1 headwinds on processed food, and whether the 6.8% dividend is safe.
Hershey (HSY) stock analysis for 2026. We examine the West Africa cocoa supply collapse, SkinnyPop and Dot's Pretzels salty snack diversification, Q1 2026 adjusted EPS of $2.35 beating $2.04 consensus, GLP-1 drug effects on candy sales, and the Mondelez rejected acquisition backstory.
Mondelez International stock analysis for 2026: Oreo, Cadbury, Ritz brand portfolio, the direct GLP-1 threat to snack demand, Clif Bar and Ricolino acquisition impacts, cocoa cost pressure, and emerging market growth as the offsetting thesis.
Coca-Cola stock analysis for 2026 covering its 62-year dividend streak, GLP-1 weight-loss drug threats to beverage demand, asset-light bottling model, segment breakdown, and Roth IRA suitability for US income investors.
PepsiCo (PEP) deep-dive for 2026: Frito-Lay structural advantage, 54-year Dividend King streak, real GLP-1 volume data, valuation vs KO, and 12-month price targets.
Procter & Gamble stock analysis for 2026 covering its 67+ year dividend streak, GLP-1 weight-loss drug implications for consumer staples, FY2024 financials, and Roth IRA suitability.